Deisenroth v. Berryhill

CourtDistrict Court, N.D. California
DecidedMarch 26, 2020
Docket3:19-cv-00614
StatusUnknown

This text of Deisenroth v. Berryhill (Deisenroth v. Berryhill) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Deisenroth v. Berryhill, (N.D. Cal. 2020).

Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 SCOTT D. DEISENROTH, Case No. 19-cv-00614-WHO

8 Plaintiff, ORDER GRANTING PLAINTIFF’S MOTION FOR SUMMARY 9 v. JUDGEMENTAND DENYING DEFENDANT’S MOTION FOR 10 NANCY A. BERRYHILL, SUMMARY JUDGEMENT; REMANDING FOR PAYMENT OF 11 Defendant. BENEFITS

12 Re: Dkt. No. 18, 25, 26

13 The parties have filed cross-motions for summary judgement in this Social Security appeal. 14 Based upon my review of the parties’ papers and the administrative record, I GRANT plaintiff 15 Scott D. Deisenroth’s motion, DENY the Commissioner’s motion, and REMAND this case for a 16 calculation and award of benefits. 17 BACKGROUND 18 I. PROCEDURAL HISTORY 19 Scott D. Deisenroth applied for Social Security Disability Insurance (“SSDI”) benefits 20 under Title II of the Social Security Act on December 23, 2015. Administrative Record (“AR”) 21 18. He initially claimed an onset date of September 1, 2015, for sleep apnea, chronic fatigue, 22 depression, and heart issues. AR 104. On December 18, 2017, he amended the onset date to 23 October 4, 2015. AR 104, 252. His application was denied initially and upon reconsideration. 24 AR 104, 113. 25 Deisenroth requested a hearing and appeared before Administrative Law Judge (“ALJ”) 26 Betty R. Barbeito on November 29, 2017. AR 38. The ALJ issued an unfavorable decision on 27 May 10, 2018. AR 1. ALJ Barbeito’s decision became the Commissioner’s final decision when 1 are Deisenroth’s motion for summary judgement, filed June 13, 2019, and the Commissioner’s 2 cross motion for summary judgement filed September 23, 2019. [Dkt. Nos. 18, 25]. 3 II. EDUCATION, WORK, AND MEDICAL HISTORY 4 Deisenroth earned a high school degree, attended some college, and has training as an 5 electrician. AR 42, 177, 415. He worked as a certified electrician until he was laid off in April 6 2015 and has been unemployed since. AR 43. 7 A. Treatment Records and Self-Reports 8 1. Sleep Apnea Specialist 9 Deisenroth began seeing Dr. Alex A. Clerk, a sleep specialist, on February 18, 2002. AR 10 311. Dr. Clerk has board certifications in “Sleep Medicine” and in “Psychiatry & Neurology.” 11 AR 313. Deisenroth was referred to Dr. Clerk because he suffered from “loud disruptive snoring 12 and difficulty maintaining sleep.” Id. During his first visit, Dr. Clerk conducted a sleep study on 13 Deisenroth and noted that he scored a seven out of 24 on the Epworth Sleepiness Scale, which is 14 considered “normal.” AR 313. But, the combination of Deisenroth’s other symptoms— 15 significant sleepiness, loud disruptive snoring, excessive caffeine consumption—indicated a 16 diagnosis of obstructive sleep apnea. Id. Dr. Clerk noted that Deisenroth was currently taking 17 Wellbutrin and concluded that he had obstructive sleep apnea, depression, and alcohol dependence 18 (in remission). AR 313-14. Dr. Clerk reviewed a “nocturnal polysomnogram” run on February 19 27, 2002 and determined the results were “consistent with Obstructive Sleep Apnea Syndrome.” 20 AR 301. He indicated that the treatment options available to Deisenroth were “weight loss, use of 21 dental devices, nasal CPAP [(continuous positive airway pressure)], and upper airway surgery.” 22 AR 313. Further, Dr. Clerk found the recommended CPAP for Deisenroth’s treatment to be 14.0 23 cm of water. Id. 24 Deisenroth visited Dr. Clerk every four to six months between 2002 and August 2017. AR 25 429. On March 27, 2009, Dr. Clerk issued a report for another nocturnal polysomnogram 26 conducted on March 25, 2009. AR 291. Based on the nocturnal polysomnogram, Dr. Clerk stated 27 Deisenroth’s recording was still “consistent with Obstructive Sleep Apnea Syndrome.” Id. To 1 On November 4, 2014, Dr. Clerk observed Deisenroth had chronic sleep apnea and 2 experienced “decreased energy” and physical fatigue. AR 268. Dr. Clerk noted Deisenroth “has 3 continued on nasal CPAP for the year” to treat his sleep apnea. Id. Further, he identified 4 Deisenroth’s “recurrent major depression” and stated that Deisenroth “sometimes has [a] death 5 wish.” AR 268-269, 271. Clerk noted that Deisenroth had previously taken Wellbutrin and 6 “would like to go back on it,” and he directed Deisenroth to restart the Wellbutrin at a specific 7 dosage. AR 268, 271. During a follow up visit on December 4, 2014, he reported that 8 Deisenroth’s sleep quality with the CPAP machine was “good,” his sleep apnea was “controlled,” 9 he had “no significant side effects,” and his compliance with treatment was “good.” AR 337. He 10 recommended that Deisenroth “[c]ontinue CPAP indefinitely” and noted Deisenroth’s CPAP was 11 set at 12.0 cm of water. AR 337, 339. Dr. Clerk noted that Deisenroth had a Wellbutrin 12 prescription and was “encouraged to fill [it].” AR 338-39. 13 Dr. Clerk issued a final report for a “Nocturnal Polysomnogram performed for CPAP 14 titration on [June 6, 2015].” AR 316. Based on the results, he recommended that Deisenroth 15 continue to use “nasal CPAP at 14.0 cm of water.” Id. In August 2015, Dr. Clerk noted that 16 Deisenroth’s sleep apnea was “controlled” and that he had “no significant side effects.” AR 334. 17 But, on the same date, Dr. Clerk recorded that Deisenroth scored a 13 out of 24 on the Epworth 18 Sleepiness Scale. Id. Though his sleep apnea was “controlled,” Dr. Clerk reported Deisenroth had 19 poor sleep quality, poor sleep hygiene (was drinking four to five cups of coffee a day), and his 20 sleep quality was poor with CPAP use (despite “excellent [treatment] compliance at 97%”). Id. In 21 response to his poor sleep quality, Dr. Clerk issued a titration study “to confirm objective 22 sleepiness despite effectiveness of CPAP.” AR 336. Dr. Clerk noted Deisenroth’s continued 23 prescription for Wellbutrin. AR 335. 24 On April 12, 2016, Deisenroth scored a 17 out of 24 on the Epworth Sleepiness Scale, 25 which correlates to “severe excess daytime sleepiness.” AR 256, 448. His sleep quality with the 26 CPAP machine was “good.” He reported no daytime hypersomnolence and “no significant side 27 effects” and continued using the CPAP at 14.0 cm of water. AR 448. However, he still had poor 1 was still depressed and his mood was “uncontrolled.” AR 449. Dr. Clerk noted that Deisenroth 2 still had a prescription for Wellbutrin but was “currently off [it].” AR 449-50. Further, 3 Deisenroth was satisfied with his therapy but Dr. Clerk opined he “still need[ed] mood 4 stabilization,” and prescribed Pristiq for Deisenroth’s anxiety and depression. AR 449, 451. 5 On May 12, 2016, he still scored a 17 out of 24 on the Epworth Sleepiness Scale. AR 452. 6 Dr. Clerk reported that Deisenroth was experiencing daytime hypersomnolence, poor sleep 7 hygiene, and fatigue, but that his sleep apnea was controlled and his sleep quality with the CPAP 8 machine was good. Id. Dr. Clerk stated Deisenroth’s treatment compliance was “excellent.” Id. 9 Dr. Clerk commented that Deisenroth’s mood was “stable and better and less irritable.” AR 453. 10 Deisenroth had prescriptions for Wellbutrin and Pristiq and Dr. Clerk stated that there was “good 11 [medication] compliance.” AR 453-54. He listed Deisenroth’s diagnoses were still obstructive 12 sleep apnea and major depression (in partial remission). AR 454. 13 On September 1, 2016, Dr. Clerk noted Deisenroth scored a 16 out of 24 on the Epworth 14 Sleepiness Scale and reported his sleep quality was “[a]verage”, but his sleep apnea was 15 “significantly better” from his previous visit. AR 456. Dr. Clerk indicated Deisenroth was using 16 CPAP set at 15.0 cm of water and “complying with nightly use with improvement in daytime 17 function.” Id. Deisenroth still experienced daytime hypersomnolence and had to “take[] daily 18 naps.” Id. Dr. Clerk reported that Deisenroth took himself off Pristiq, which he had been taking 19 for depression. AR 458.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Richardson v. Perales
402 U.S. 389 (Supreme Court, 1971)
Molina v. Astrue
674 F.3d 1104 (Ninth Circuit, 2012)
Debbra Hill v. Michael Astrue
698 F.3d 1153 (Ninth Circuit, 2012)
Orn v. Astrue
495 F.3d 625 (Ninth Circuit, 2007)
Lingenfelter v. Astrue
504 F.3d 1028 (Ninth Circuit, 2007)
Karen Garrison v. Carolyn W. Colvin
759 F.3d 995 (Ninth Circuit, 2014)
Ramirez-Lluveras v. Rivera-Merced
759 F.3d 10 (First Circuit, 2014)
Adrian Burrell v. Carolyn W. Colvin
775 F.3d 1133 (Ninth Circuit, 2014)
Robbins v. Social Security Administration
466 F.3d 880 (Ninth Circuit, 2006)
Bernard Laborin v. Nancy Berryhill
867 F.3d 1151 (Ninth Circuit, 2017)
Gavin Buck v. Nancy Berryhill
869 F.3d 1040 (Ninth Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Deisenroth v. Berryhill, Counsel Stack Legal Research, https://law.counselstack.com/opinion/deisenroth-v-berryhill-cand-2020.